A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Proteome Research

• Publication date

  2009-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/pr800876zPMID 19441803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis

  2009cited by this paper
• Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia.

  2009cited by this paper
• Schizophrenia therapy: beyond atypical antipsychotics

  2008cited by this paper
• Shared gene expression alterations in schizophrenia and bipolar disorder.

  2008cited by this paper
• Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu.

  2007cited by this paper
• Sp1 Expression Is Disrupted in Schizophrenia; A Possible Mechanism for the Abnormal Expression of Mitochondrial Complex I Genes, NDUFV1 and NDUFV2

  2007cited by this paper
• Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study.

  2007cited by this paper
• Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro

  2007cited by this paper
• Review of the literature on major mental disorders in adult patients with mitochondrial diseases.

  2006cited by this paper
• Differential Expression Profiling of the Hepatic Proteome in a Rat Model of Dioxin Resistance

  2006cited by this paper
• New variants in the mitochondrial genomes of schizophrenic patients

  2006cited by this paper
• The calcium-sensitive large-conductance potassium channel (BK/MAXI K) is present in the inner mitochondrial membrane of rat brain.

  2006cited by this paper
• Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes

  2006cited by this paper
• MAPK-activated Protein Kinase 2 Deficiency in Microglia Inhibits Pro-inflammatory Mediator Release and Resultant Neurotoxicity

  2006cited by this paper
• Comparative Proteomic Analysis Provides New Insights into Chilling Stress Responses in Rice*

  2006cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.

  2005cited by this paper
• Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.

  2005cited by this paper
• Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.

  2005cited by this paper
• Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.

  2004cited by this paper
• Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders.

  2004cited by this paper
• Comparative proteome analysis of thalamus in MK‐801‐treated rats

  2004cited by this paper
• Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

  2004cited by this paper
• Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.

  2004cited by this paper
• Activation-dependent surface expression of gC1qR/p33 on human blood platelets

  2003cited by this paper
• Differential effects of typical and atypical neuroleptics on mitochondrial functionin vitro

  2003cited by this paper
• Comparative genome‐ and proteome analysis of cerebral cortex from MK‐801‐treated rats

  2003cited by this paper
• Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

  2003cited by this paper
• Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

  2002cited by this paper
• Glucose/mitochondria in neurological conditions.

  2002cited by this paper
• Translation control: bridging the gap between genomics and proteomics?

  2001cited by this paper
• Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.

  2001cited by this paper
• Advances in schizophrenia

  2001cited by this paper
• Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.

  2000cited by this paper
• Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic Schizophrenics

  1999cited by this paper
• Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study

  1999cited by this paper
• Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria

  1999cited by this paper
• Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation.

  1999cited by this paper
• Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats

  1998cited by this paper
• Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients

  1998cited by this paper
• Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow.

  1997cited by this paper
• Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics

  1997cited by this paper
• Mitochondrial involvement in schizophrenia and other functional psychoses

  1996cited by this paper
• Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

  1995cited by this paper
• A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening.

  1995cited by this paper
• Rat Tissue Concentrations of Chlorimipramine, Chlorpromazine and their N‐Demethylated Metabolites after a Single Oral Dose of the Parent Compounds

  1995cited by this paper
• Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds.

  1995cited by this paper
• Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic Neurotoxicity

  1994cited by this paper
• Catalytic sector of complex I (NADH:ubiquinone oxidoreductase): subunit stoichiometry and substrate-induced conformation changes.

  1994cited by this paper
• Neuroleptic medications inhibit complex I of the electron transport chain

  1993cited by this paper
• Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

  1993cited by this paper

• Multi-omics identification and validation of oxidative phosphorylation–related hub genes in schizophrenia

  2025cites this paper
• Clinical and molecular implications of antipsychotics in MASLD.

  2025cites this paper
• Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia

  2025cites this paper
• Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment

  2023cites this paper
• Clozapine-Induced Myocarditis: Pathophysiologic Mechanisms and implications for therapeutic approaches.

  2022cites this paper
• Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacy

  2022cites this paper
• Mitochondrial dysfunction in psychiatric disorders.

  2022cites this paper
• Idebenone Regulates Aβ and LPS-Induced Neurogliosis and Cognitive Function Through Inhibition of NLRP3 Inflammasome/IL-1β Axis Activation

  2022cites this paper
• Decreased Brain pH and Pathophysiology in Schizophrenia

  2021influential citation
• The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions

  2021cites this paper
• CPEB1, a novel risk gene in recent-onset schizophrenia, contributes to mitochondrial complex I defect caused by a defective provirus ERVWE1

  2021cites this paper
• Effects of psychoactive drugs on cellular bioenergetic pathways

  2020cites this paper
• Mitochondrial Dysfunction in Schizophrenia

  2020cites this paper
• The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders

  2020cites this paper
• Oxidative stress as a problem of psychopharmacology

  2020cites this paper
• Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review

  2019cites this paper
• Impact of pharmacological agents on mitochondrial function: a growing opportunity?

  2019cites this paper
• NDT_A_208061 2087..2099

  2019cites this paper
• Psychiatric drugs impact mitochondrial function in brain and other tissues.

  2019cites this paper
• Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia.

  2018cites this paper
• 17 Mitochondrial Proteomics : From Structure to Function

  2018cites this paper
• Proteomic study revealed antipsychotics-induced nuclear protein regulations in B35 cells are similar to the regulations in C6 cells and rat cortex

  2018cites this paper
• Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes

  2017cites this paper
• Mechanism 1 : Insulin Resistance Due to Direct Effect of Antipsychotics

  2017cites this paper
• OLANZAPINE COMBINED WITH ETHANOL MODULATES THE ACTIVITY OF MITOCHONDRIAL ENZYMES AND ACETYLCHOLINESTERASE IN METHYLPHENIDATE INDUCED MANIA

  2017cites this paper
• Transcriptome Analysis of Systems Biology for Schizophrenia

  2016cites this paper
• Stathmin reduction and cytoskeleton rearrangement in rat nucleus accumbens in response to clozapine and risperidone treatment - Comparative proteomic study.

  2016cites this paper
• loproteinase‐9, myosin heavy chain 10, actin‐related protein‐3 homolog, elongation factor 1‐α‐1 (EF‐1‐α‐1), and acidic ribo- somal phosphoprotein P0. Five of the twelve proteins were associated with cellular proliferation: DNA‐dependent protein kinase catalytic subunit, EF‐1‐α‐1, tyrosine 3‐monooxyg

  2016cites this paper
• Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia

  2016cites this paper
• Effect of in utero exposure to the atypical anti‐psychotic risperidone on histopathological features of the rat placenta

  2016cites this paper
• Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes

  2016influential citation
• Proteome effects of antipsychotic drugs: Learning from preclinical models

  2016influential citation
• Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder

  2016cites this paper
• Label-free LC-MS/MS shotgun proteomics to investigate the anti-inflammatory effect of rCC16

  2016cites this paper
• Effect of Prolonged Simulated Microgravity on Metabolic Proteins in Rat Hippocampus: Steps toward Safe Space Travel.

  2016cites this paper
• Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia

  2016cites this paper
• Blood lactate levels as a biomarker of antipsychotic side effects in patients with schizophrenia

  2016cites this paper
• NDUFV2 regulates neuronal migration in the developing cerebral cortex through modulation of the multipolar-bipolar transition.

  2015cites this paper
• The proteome of schizophrenia

  2015cites this paper
• iTRAQ-based quantitative analysis of hippocampal postsynaptic density-associated proteins in a rat chronic mild stress model of depression.

  2015cites this paper
• Acute and Chronic Treatments with Quetiapine Increase Mitochondrial Respiratory Chain Complex Activity in the Rat Brain.

  2015cites this paper
• What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?

  2015cites this paper
• Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.

  2015cites this paper
• Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy.

  2015cites this paper
• Proteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome

  2015cites this paper
• Insights from Proteomic Studies on Schizophrenia Preclinical Models: What Can We Learn for Drug Discovery?

  2014cites this paper
• Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome.

  2014cites this paper
• Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders

  2014cites this paper
• Metabolomic pro fi ling of schizophrenia patients at risk for metabolic syndrome

  2014cites this paper
• Recent advances in quantitative neuroproteomics.

  2013cites this paper
• Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells

  2013cites this paper
• Central regulation of blood pressure in hypertension

  2012cites this paper
• Molecular links between mitochondrial dysfunctions and schizophrenia

  2012cites this paper
• Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction

  2012cites this paper
• Effect of Atypical Antipsychotics on Fetal Growth: Is the Placenta Involved?

  2012cites this paper
• Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide

  2012cites this paper
• Proteomic biomarkers for psychiatric disorders: a progress update.

  2012cites this paper
• Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine.

  2012cites this paper
• Mitochondrial Proteomics: From Structure to Function

  2012cites this paper
• Mitochondrial respiratory chain defects in autism and other neurodevelopmental disorders

  2012cites this paper
• Genomics and pharmacogenomics of brain disorders.

  2012cites this paper
• Translational strategies to schizophrenia from a proteomic perspective

  2012cites this paper
• Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain

  2011cites this paper
• Energy matters: Mitochondrial proteomics for biomedicine

  2011cites this paper
• The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

  2011cites this paper
• Genomics and Pharmacogenomics of Schizophrenia

  2011cites this paper
• Quantitative proteomics for investigating psychiatric disorders

  2011cites this paper
• Pharmacogenomics of antipsychotics efficacy for schizophrenia

  2011cites this paper
• Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese

  2010cites this paper
• Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease

  2010cites this paper
• Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants

  2010cites this paper
• A meta-analysis of oxidative stress markers in schizophrenia

  2010cites this paper
• Oxidative stress, antioxidant defenses, and schizophrenia

  2010cites this paper
• Toward quantitative proteomics of organ substructures: implications for renal physiology.

  2010cites this paper
• Transcriptomic evidence implicates ribosomal and energy metabolic pathways in antiepileptic drug action in a Drosophila model

  2009cites this paper
• Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis.

  2009cites this paper
• Transcriptomic analysis implicates ribosomal and energy metabolic pathways in antiepileptic drug action in a Drosophila model

  2009cites this paper